SyncoZymes

nkhani

Nkhani yabwino: Shangke Bio yadziwika ngati projekiti yopambana kwambiri

Pa Januware 5, 2021, Shangke Biopharmaceutical (Shanghai) Co., Ltd. inapatsidwa "(S) -1-tert-butoxycarbonyl-3-hydroxypiperidine" Shanghai High-tech Achievement Transformation Project.

Monga bizinesi yaukadaulo yapadziko lonse, Suntech Biotech nthawi zonse imatenga sayansi yasayansi kutsogolera chitukuko chamakampani opanga mankhwala ndi mankhwala, ndipo imabweretsa zobiriwira ndi thanzi kwa anthu monga cholinga chake.Kukulitsa bizinesiyo m'njira zambiri, gwirizanani mwachangu ndi masukulu odziwika bwino komanso mabizinesi kunyumba ndi kunja, nthawi zonse kukulitsa luso lake lachitukuko, kukhathamiritsa kasinthidwe ka bizinesiyo, ndikukhala bwino komanso mwamphamvu.

kupambana kwaukadaulo wapamwamba

Dzina la polojekiti: (S) -1-tert-Butoxycarbonyl-3-hydroxypiperidine
Nambala yazinthu: 202010694
Mlingo wa chinthu: B
Kaya pali zopambana pazaukadaulo wapamwamba wokhala ndi ufulu wodziyimira pawokha wamimisiri: Inde

Kugwiritsa ntchito: (S) -1-tert-butoxycarbonyl-3-hydroxypiperidine (CAS: 143900-44-1) ndizofunikira kwambiri zapakati pa kaphatikizidwe ka ibrutinib APIs.Ibrutinib ndi mankhwala atsopano oletsa khansa omwe akuloza zilonda za B-cell zomwe zidavomerezedwa ndi kuvomerezedwa ndi US Food and Drug Administration (FDA) pa Novembara 13, 2013 kuti athe kuchiza lymphoma.

Tanthauzo la kusintha kwapamwamba kwapamwamba
Kusintha kwazomwe zachitika mwaukadaulo kumatanthawuza njira yomwe mabizinesi amapangira zida zapamwamba komanso ntchito.Boma limathandizira mabizinesi kuti agwiritse ntchito kusintha kwa zomwe akwaniritsa zasayansi ndiukadaulo kudzera pakufufuza kodziyimira pawokha ndi chitukuko, kupereka ziphaso, kutenga magawo pamtengo, komanso kugwirizana ndi mafakitale, mayunivesite ndi mabungwe ofufuza.Pama projekiti apamwamba kwambiri osinthika omwe amawunikiridwa ndikufotokozedwa ndi bizinesiyo, malinga ndi kukwaniritsidwa kwa ziwonetsero zake zazachuma komanso mawonekedwe aufulu waukadaulo wa polojekitiyi, kuchuluka kwazinthu zatsopano, ndi zina zambiri, ndalama zake za R&D zikugwirizana ndi polojekitiyi. -maufulu okhudzana ndi katundu wanzeru, ziphaso zapatent zopanga, kapena omwe akulowa muyeso yayikulu.Satifiketi yaulemu yomwe idaperekedwa kubizinesi itatha kuunikanso mozama komanso kufufuzidwa bwino kwa msika, monga zida zotsimikizira za kugwiritsa ntchito patent, satifiketi yapatent yachitsanzo, satifiketi yolembetsa copyright ya pulogalamu, satifiketi yolembetsa yophatikizika yamagawo, ndi zina zambiri.

Mbiri Yakampani
Shangke Biomedical (Shanghai) Co., Ltd. inakhazikitsidwa mu 2008 ndipo ili ku International Medical Park, kumwera kwa Zhangjiang Hi-Tech Park, Pudong, Shanghai.Ndi kampani yocheperapo ya Zhejiang Shangke Biomedical Co., Ltd. Shangke Bio yadzipereka pa kafukufuku ndi chitukuko cha malo opangira mankhwala obiriwira kwambiri, amatsogolera kutukuka kwa makampani opanga mankhwala okhala ndi sayansi yobiriwira, ndipo amapereka nzeru zatsopano. mankhwala ndi ntchito zapamwamba zamakampani opanga mankhwala.Ndi bizinesi yapamwamba ku Shanghai komanso bizinesi yaukadaulo ya Shanghai "Yapadera, yoyengedwa, yapadera komanso yatsopano".

Bizinesi yayikulu ya Suntech imaphatikizapo: kupanga ndi kugwiritsa ntchito ma enzymes achilengedwe, kupanga ndi kupanga mankhwala ophatikizira, ma API ndi mankhwala ogwira ntchito.Zogulitsa zazikulu za kampaniyi ndi zinthu za coenzyme, kuphatikiza NMN, NAD, NADP, NADH, NADPH, michere yazachilengedwe, zopangira zamankhwala ndi zapakati.Makasitomala a kampaniyo ndi othandizana nawo ali padziko lonse lapansi, ndipo apanga ubale wolimba ndi makampani ambiri azamankhwala ku North America, Europe, India ndi China.


Nthawi yotumiza: Jan-15-2021